These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 17512554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ENOS is not activated by nebivolol in human failing myocardium.
    Brixius K, Song Q, Malick A, Boelck B, Addicks K, Bloch W, Mehlhorn U, Schwinger RH.
    Life Sci; 2006 Aug 22; 79(13):1234-41. PubMed ID: 16716362
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker.
    Ignarro LJ.
    Blood Press Suppl; 2004 Oct 22; 1():2-16. PubMed ID: 15587107
    [Abstract] [Full Text] [Related]

  • 5. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
    Baumhäkel M, Schlimmer N, Büyükafsar K, Arikan O, Böhm M.
    J Pharmacol Exp Ther; 2008 Jun 22; 325(3):818-23. PubMed ID: 18364472
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S, Wright HM.
    Cardiovasc Ther; 2008 Jun 22; 26(3):189-202. PubMed ID: 18786089
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phosphorylated endothelial nitric oxide synthase mediates vascular endothelial growth factor-induced penile erection.
    Musicki B, Palese MA, Crone JK, Burnett AL.
    Biol Reprod; 2004 Feb 22; 70(2):282-9. PubMed ID: 14522830
    [Abstract] [Full Text] [Related]

  • 12. Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium.
    Brixius K, Bloch W, Ziskoven C, Bölck B, Napp A, Pott C, Steinritz D, Jiminez M, Addicks K, Giacobino JP, Schwinger RH.
    Can J Physiol Pharmacol; 2006 Oct 22; 84(10):1051-60. PubMed ID: 17328145
    [Abstract] [Full Text] [Related]

  • 13. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
    Ignarro LJ.
    Cardiovasc Ther; 2008 Oct 22; 26(2):115-34. PubMed ID: 18485134
    [Abstract] [Full Text] [Related]

  • 14. Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.
    Maffei A, Di Pardo A, Carangi R, Carullo P, Poulet R, Gentile MT, Vecchione C, Lembo G.
    Hypertension; 2007 Oct 22; 50(4):652-6. PubMed ID: 17664392
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A, Popov D, Dragan E, Dragomir E, Badila E.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):149-58. PubMed ID: 17612521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of nitric oxide release by nebivolol and its metabolites.
    Maffei A, Vecchione C, Aretini A, Poulet R, Bettarini U, Gentile MT, Cifelli G, Lembo G.
    Am J Hypertens; 2006 Jun 10; 19(6):579-86. PubMed ID: 16733229
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.